/Investor DB

ACORN BIOVENTURES — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Q32 Bioq32bio.comin𝕏NASDAQ: QTTBSeries B · Oct 2020 · $60M

Q32 Bio is a biotechnology company developing therapies for autoimmune and inflammatory diseases, with a scientific focus on the complement system and immune regulation in conditions such as inflammation, autoimmunity and fibrosis.

BiotechHealthtech

Shelia Violette(Founder & Chief Scientific Officer)inMichael Holers(Co-founder)Jodie Morrison(Chief Executive Officer)inLee Kalowski(President & Chief Financial Officer)Maria Marzilli(Chief Business Officer)inDavid Appugliese(Senior Vice President, Head of People)in

Co-investorsAtlas VentureOrbiMedAgent CapitalCU Healthcare Innovation FundOUP (Osage University Partners)Sanofi Ventures+2 more

Fitefite.tvin𝕏Nov 2020 · $22MAcquired

TrillerTV is a direct-to-consumer sports streaming platform operated by Flipps Media, offering live pay-per-view events, subscriptions, and on-demand content featuring combat sports, wrestling, and entertainment programming.

ConsumerMedia & EntertainmentSports TechEncino, US

Co-investorsEarlybird Venture CapitalLAUNCHub VenturesBrightCap Investment Advisor ADPoint72 Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.